← 產業報告目錄
Rheumatoid Arthritis Diagnostic Tests Market Size, Share & Trends Analysis Report By Test Type (Serology Test (Erythrocyte Sedimentation Rate (ESR), Rheumatoid Factor (RF), Anti-cyclic Citrullinated Peptide (anti-CCP), Antinuclear Antibody (ANA), Uric Acid, Other Tests), Monitoring RA Treatment Efficiency Tests, By End User, By Region, And By Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-21頁數 165報告編號 INSIGHTACE-6498302883
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 2.03 billion, the global Rheumatoid Arthritis Diagnostic Tests Market is forecasted to expand to USD 3.19 billion by 2031, demonstrating a CAGR of 6.05% during the 2024–2031 forecast window.
Rheumatoid Arthritis Diagnostic Tests covers reshaping how healthcare entities approach this space.
Market momentum is supported by expanding interest in advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Rheumatoid Arthritis Diagnostic Test Market Snapshot
Chapter 4. Global Rheumatoid Arthritis Diagnostic Test Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Test Type Estimates & Trend Analysis
5.1. By Test Type & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Test Type:
5.2.1. Serology Test
5.2.1.1. Erythrocyte Sedimentation Rate (ESR)
5.2.1.2. Rheumatoid Factor (RF)
5.2.1.3. Anti-cyclic Citrullinated Peptide (anti-CCP)
5.2.1.4. Antinuclear Antibody (ANA)
5.2.1.5. Uric Acid
5.2.1.6. Other Tests
5.2.2. Monitoring RA Treatment Efficiency Tests
5.2.2.1. Salicylate Level Count
5.2.2.2. Muscle Enzyme Tests (CPK, Aldolase)
5.2.2.3. Creatinine Test
Chapter 6. Market Segmentation 2: By End Users Estimates & Trend Analysis
6.1. By End Users & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following By End Users:
6.2.1. Diagnostic Laboratories
6.2.2. Private Laboratories
6.2.3. Public Laboratories
6.2.4. Ambulatory Surgical Centers
Chapter 7. Rheumatoid Arthritis Diagnostic Test Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.1.2. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.1.3. North America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.2. Europe
7.2.1. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.2.2. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.2.3. Europe Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.3.2. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.3.3. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.4. Latin America
7.4.1. Asia Pacific Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.4.2. Latin America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.4.3. Latin America Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by Test Type, 2024-2031
7.5.2. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by End Users, 2024-2031
7.5.3. Middle East & Africa Rheumatoid Arthritis Diagnostic Test Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Abbott Laboratories Inc.
8.2.2. Siemens Healthineers AG
8.2.3. Thermo Fisher Scientific Inc.
8.2.4. Exagen Inc.
8.2.5. Augurex Life Sciences Corp.
8.2.6. Danaher Corporation
8.2.7. Bio-Rad Laboratories, Inc.
8.2.8. Tulip Diagnostics (P) Ltd
8.2.9. Boditech Med Inc.
8.2.10. Labcorp,
8.2.11. Antibodies Inc.,
8.2.12. Beckman Coulter, Inc.,
8.2.13. Euro Diagnostica AB,
8.2.14. F. Hoffmann-La Roche Ltd.,
8.2.15. Qiagen NV,
8.2.16. Specialty Networks, LLC
8.2.17. Genway Biotech, Inc.,
8.2.18. Microdrop LLC (imaware)
8.2.19. Svar Life Science AB,
8.2.20. Others Market Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們